Embolotherapy Market Analysis and Forecast to 2031: By Product (Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices), Application (Oncology, Peripheral Vascular Devices, Urology & Nephrology, Neurology, GIT Disord
Description
Embolotherapy Market Analysis and Forecast to 2031: By Product (Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices), Application (Oncology, Peripheral Vascular Devices, Urology & Nephrology, Neurology, GIT Disorders), Procedures (Transcatheter Arterial Embolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, Transarterial Chemoembolization), End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others), and Region
The global Embolotherapy market was valued at USD 3.8 billion in 2021 and it is anticipated to grow up to USD 7.7 billion by 2031, at a CAGR of 7.3% during the forecast period.
Embolotherapy is the process of obstructing arteries with a device (such as a balloon catheter) in order to treat or stop uncontrollable bleeding. Utilizing this technique, tumors are reduced, and bleeding is controlled. It is an endovascular procedure that attempts to stop bleeding by restricting aberrant blood arteries. Embolotherapy is mostly used to treat cervical uprooted pregnancy, postpartum situations, and pelvic tract hemorrhage.
This treatment has shown promise in the management of iatrogenic solid organ, vascular, and non-operative organ damage, including lesions to the liver, spleen, and kidneys. Embolotherapy is used to treat enlarged uterine fibroids, de vascularize tissues and organs prior to surgery, and eliminate duodenal varices. This necessitates choosing an embolization agent with the required level of vascular blockage permanence.
Global Embolotherapy Market Scope and Report StructureMarket Drivers and Trends
Because more target procedures are being performed on more target patients, the market for embolotherapy devices has been rising steadily over the past ten years. CVD is a major target illness, and research on successful and efficient treatments has focused on it because of its significance and high prevalence. Globally, more than 200 million people have peripheral vascular disorders as of 2017. The prevalence of these disorders increases with age, with the over-80 age group showing a prevalence rate of more than 20%.
The market for embolotherapy devices will likely increase in the near future due to the high success rate and low postoperative complication rate associated with embolotherapy procedures as well as the rising prevalence of liver cancer and hepatocellular carcinoma. The fifth most prevalent cancer in males and the ninth most common in women is liver cancer. Over 840,000 new cases were diagnosed globally in 2018. World Cancer Research Fund, a source. In addition, incidence rates of kidney cancer rose by 42% in the UK over the previous ten years. Male incidence rates were 38 percent, compared to a 44 percent increase in female incidence rates.
Market Restraints and Challenges
The availability of efficient first-level conventional medicines for the management of hemorrhagic disorders such as liver cancer, uterine fibroids, hemorrhagic stroke, and other hemorrhagic conditions is a major market growth inhibitor. For example, therapies like surgery, chemotherapy, and radiation therapy are preferred options in the treatment of cancer due to the high awareness of conventional cancer treatments among the general public, the low adoption of advanced treatment options (especially in developing countries), and the reluctance of oncologists to use alternative therapies.
Global Embolotherapy Market Segmental Overview
The report analyses the global embolotherapy market based on product, application, procedure, end user, and region.
Global Embolotherapy Market by Product
Based on product, it is segmented into embolization coil, embolic agents, detachable balloons, embolic plug systems, and support devices. The embolic agents segment is likely to dominate the market during the forecast period. The market growth of this segment is primarily driven by the surge in the prevalence of hepatocellular carcinoma combined with favorable reimbursement criteria in developed economies. Likewise, new product launches and approvals are further boosting the growth of the market.
Global Embolotherapy Market by Application
Based on application, it is segmented into cancer, peripheral vascular diseases, neurological diseases, urological & nephrological disorders, and gastrointestinal disorders. The cancer segment is likely to hold the major share of the market. The growing incidences of liver cancer & kidney cancer coupled with the respective adoption of TACE and TARE procedures are boosting the growth of the market.
Global Embolotherapy Market by Procedure
Based on procedure, it is segmented into transcatheter arterial embolization, transcatheter arterial chemoembolization, and transcatheter arterial radioembolization/selective internal radiation therapy. The transcatheter arterial embolization segment is likely to dominate the market during the forecast period. The key factors such as increasing demand for minimally invasive procedures coupled with growing prevalence of chronic diseases and rapid growth in the geriatric population are boosting the growth of the market.
Global Embolotherapy Market by End User
Based on end user, it is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals and clinics segment is likely to dominate the market during the forecast period. The key factors such as growing adoption of minimally invasive surgical procedures (including vascular, urological, and neurological), increasing purchasing power of major healthcare providers across developed countries (owing to the consolidation of healthcare providers), and the greater availability of reimbursements for target procedures in the US and major European countries are the major factors that are expected to drive the demand for embolization devices in hospitals and clinics.
Geographical Analysis of Global Embolotherapy Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific market is expected to hold the majority of the market share during the forecast period. Improving healthcare infrastructure in the region, the large patient population for target diseases, and expanding presence of key market players in the region to grab elevating opportunities offered by these countries are the key factors supporting the market growth in this region.
Major Players in the Global Embolotherapy MarketCOVID-19 Impact:
A decline in sales is being observed in the embolotherapy sector, and this trend is predicted to last until December 2020. This industry's expansion is being hampered by unfavourable changes to the rules and regulations. Cancer patients are more likely to contract COVID-19 infection than healthy persons, according to major regulatory agencies throughout the world (including the CDC, WHO, MHRA, TGA, and EMA). As a result, screening, diagnostic tests, and surgical operations are severely limited or put off at hospitals and cancer treatment facilities. Market disruption for embolotherapy is anticipated as a result.
Recent Developments:
Q1. How big is the Embolotherapy market?Ans. The global Embolotherapy market size was USD 3.8 Billion in 2021 and is anticipated to reach USD 7.7 Billion in 2031, growing at a rate of 7.3% from 2022 to 2031.
Q2. What is the Embolotherapy market growth rate?Ans. The growth rate of the Embolotherapy market is 7.3% from 2022 to 2031.
Q3. Which region holds a major market share for the Embolotherapy market?Ans. North America holds a major market share of the Embolotherapy market in 2021.
Q4. Which segment accounted for the largest Embolotherapy market share?Ans. By end user, the hospitals & clinics segment accounted for the largest Embolotherapy market share.
Q5. Who are the key players in the Embolotherapy market?Ans. The global Embolotherapy market report includes players such as
Q6. What are the factors driving the Embolotherapy market growth?Ans. The major factors driving the growth of the market are expanding applications of Embolotherapy devices.
Q7. What are the key growth strategies of Embolotherapy market players?Ans. The key growth strategies of Embolotherapy market players are product launch and product approval.
Q8. Which region will provide more business opportunities for the Embolotherapy market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Embolotherapy market during the forecast period.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
The global Embolotherapy market was valued at USD 3.8 billion in 2021 and it is anticipated to grow up to USD 7.7 billion by 2031, at a CAGR of 7.3% during the forecast period.
Embolotherapy is the process of obstructing arteries with a device (such as a balloon catheter) in order to treat or stop uncontrollable bleeding. Utilizing this technique, tumors are reduced, and bleeding is controlled. It is an endovascular procedure that attempts to stop bleeding by restricting aberrant blood arteries. Embolotherapy is mostly used to treat cervical uprooted pregnancy, postpartum situations, and pelvic tract hemorrhage.
This treatment has shown promise in the management of iatrogenic solid organ, vascular, and non-operative organ damage, including lesions to the liver, spleen, and kidneys. Embolotherapy is used to treat enlarged uterine fibroids, de vascularize tissues and organs prior to surgery, and eliminate duodenal varices. This necessitates choosing an embolization agent with the required level of vascular blockage permanence.
Global Embolotherapy Market Scope and Report StructureMarket Drivers and Trends
Because more target procedures are being performed on more target patients, the market for embolotherapy devices has been rising steadily over the past ten years. CVD is a major target illness, and research on successful and efficient treatments has focused on it because of its significance and high prevalence. Globally, more than 200 million people have peripheral vascular disorders as of 2017. The prevalence of these disorders increases with age, with the over-80 age group showing a prevalence rate of more than 20%.
The market for embolotherapy devices will likely increase in the near future due to the high success rate and low postoperative complication rate associated with embolotherapy procedures as well as the rising prevalence of liver cancer and hepatocellular carcinoma. The fifth most prevalent cancer in males and the ninth most common in women is liver cancer. Over 840,000 new cases were diagnosed globally in 2018. World Cancer Research Fund, a source. In addition, incidence rates of kidney cancer rose by 42% in the UK over the previous ten years. Male incidence rates were 38 percent, compared to a 44 percent increase in female incidence rates.
Market Restraints and Challenges
The availability of efficient first-level conventional medicines for the management of hemorrhagic disorders such as liver cancer, uterine fibroids, hemorrhagic stroke, and other hemorrhagic conditions is a major market growth inhibitor. For example, therapies like surgery, chemotherapy, and radiation therapy are preferred options in the treatment of cancer due to the high awareness of conventional cancer treatments among the general public, the low adoption of advanced treatment options (especially in developing countries), and the reluctance of oncologists to use alternative therapies.
Global Embolotherapy Market Segmental Overview
The report analyses the global embolotherapy market based on product, application, procedure, end user, and region.
Global Embolotherapy Market by Product
Based on product, it is segmented into embolization coil, embolic agents, detachable balloons, embolic plug systems, and support devices. The embolic agents segment is likely to dominate the market during the forecast period. The market growth of this segment is primarily driven by the surge in the prevalence of hepatocellular carcinoma combined with favorable reimbursement criteria in developed economies. Likewise, new product launches and approvals are further boosting the growth of the market.
Global Embolotherapy Market by Application
Based on application, it is segmented into cancer, peripheral vascular diseases, neurological diseases, urological & nephrological disorders, and gastrointestinal disorders. The cancer segment is likely to hold the major share of the market. The growing incidences of liver cancer & kidney cancer coupled with the respective adoption of TACE and TARE procedures are boosting the growth of the market.
Global Embolotherapy Market by Procedure
Based on procedure, it is segmented into transcatheter arterial embolization, transcatheter arterial chemoembolization, and transcatheter arterial radioembolization/selective internal radiation therapy. The transcatheter arterial embolization segment is likely to dominate the market during the forecast period. The key factors such as increasing demand for minimally invasive procedures coupled with growing prevalence of chronic diseases and rapid growth in the geriatric population are boosting the growth of the market.
Global Embolotherapy Market by End User
Based on end user, it is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals and clinics segment is likely to dominate the market during the forecast period. The key factors such as growing adoption of minimally invasive surgical procedures (including vascular, urological, and neurological), increasing purchasing power of major healthcare providers across developed countries (owing to the consolidation of healthcare providers), and the greater availability of reimbursements for target procedures in the US and major European countries are the major factors that are expected to drive the demand for embolization devices in hospitals and clinics.
Geographical Analysis of Global Embolotherapy Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific market is expected to hold the majority of the market share during the forecast period. Improving healthcare infrastructure in the region, the large patient population for target diseases, and expanding presence of key market players in the region to grab elevating opportunities offered by these countries are the key factors supporting the market growth in this region.
Major Players in the Global Embolotherapy MarketCOVID-19 Impact:
A decline in sales is being observed in the embolotherapy sector, and this trend is predicted to last until December 2020. This industry's expansion is being hampered by unfavourable changes to the rules and regulations. Cancer patients are more likely to contract COVID-19 infection than healthy persons, according to major regulatory agencies throughout the world (including the CDC, WHO, MHRA, TGA, and EMA). As a result, screening, diagnostic tests, and surgical operations are severely limited or put off at hospitals and cancer treatment facilities. Market disruption for embolotherapy is anticipated as a result.
Recent Developments:
- March 2021, Kaneka has received FDA approval of the Thera Sphere Y-90 Glass Microspheres, developed for the treatment of patients with hepatocellular carcinoma.
- March 2021, Boston Scientific has received US Food and Drug Administration approval of the Thera Sphere Y-90 Glass Microspheres.
- January 2021, Terumo Corporation has the FDA approval of the PMA supplement for the WEB 17 System, a new addition to the WEB Aneurysm Embolization System for the treatment of intracranial wide-neck bifurcation aneurysms.
Q1. How big is the Embolotherapy market?Ans. The global Embolotherapy market size was USD 3.8 Billion in 2021 and is anticipated to reach USD 7.7 Billion in 2031, growing at a rate of 7.3% from 2022 to 2031.
Q2. What is the Embolotherapy market growth rate?Ans. The growth rate of the Embolotherapy market is 7.3% from 2022 to 2031.
Q3. Which region holds a major market share for the Embolotherapy market?Ans. North America holds a major market share of the Embolotherapy market in 2021.
Q4. Which segment accounted for the largest Embolotherapy market share?Ans. By end user, the hospitals & clinics segment accounted for the largest Embolotherapy market share.
Q5. Who are the key players in the Embolotherapy market?Ans. The global Embolotherapy market report includes players such as
Q6. What are the factors driving the Embolotherapy market growth?Ans. The major factors driving the growth of the market are expanding applications of Embolotherapy devices.
Q7. What are the key growth strategies of Embolotherapy market players?Ans. The key growth strategies of Embolotherapy market players are product launch and product approval.
Q8. Which region will provide more business opportunities for the Embolotherapy market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Embolotherapy market during the forecast period.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
213 Pages
- Chapter 1. Market Introduction
- 1.1. Objectives of the study
- 1.2. Market definition and research & scope
- 1.3. Research methodologies
- 1.4. Market estimation techniques
- Chapter 2. Executive Summary
- 2.1. Summary
- 2.2. Key highlights of the market
- Chapter 3. Embolotherapy Market Outlook
- 3.1. Embolotherapy market segmentation
- 3.2. Market dynamics
- 3.2.1. Market drivers
- 3.2.1.1. Driver 1
- 3.2.1.2. Driver 2
- 3.2.1.3. Driver 3
- 3.2.2. Market restraints
- 3.2.2.1. Restraint 1
- 3.2.2.2. Restraint 2
- 3.2.3. Market opportunities
- 3.2.3.1. Opportunity 1
- 3.2.3.2. Opportunity 2
- 3.3. Porter’s five forces analysis
- 3.3.1. Threat of new entrants
- 3.3.2. Threat of substitutes
- 3.3.3. Bargaining power of buyers
- 3.3.4. Bargaining power of supplier
- 3.3.5. Competitive rivalry
- 3.4. Pestle analysis
- 3.5. Value chain analysis
- 3.5.1. Raw material suppliers
- 3.5.2. Manufacturers
- 3.5.3. Wholesalers and/or retailers
- 3.6. Impact of the Russia and Ukraine war on the global Embolotherapy market
- Chapter 4. The Economic Impact of Covid-19
- 4.1. Overall impact of covid-19
- 4.2. Impact of covid on the global Embolotherapy market
- 4.3. Economic impact analysis
- Chapter 5. Embolotherapy Market by Product
- 5.1. Market overview
- 5.2. Embolization Coil
- 5.2.1. Market size and forecast, 2021-2031 ($million)
- 5.2.2. Market size and forecast, by region, 2021-2031 ($million)
- 5.3. Embolic Agents
- 5.3.1. Market size and forecast, 2021-2031 ($million)
- 5.3.2. Market size and forecast, by region, 2021-2031 ($million)
- 5.4. Detachable Balloons
- 5.4.1. Market size and forecast, 2021-2031 ($million)
- 5.4.2. Market size and forecast, by region, 2021-2031 ($million)
- 5.5. Embolic Plug Syndrome
- 5.5.1. Market size and forecast, 2021-2031 ($million)
- 5.5.2. Market size and forecast, by region, 2021-2031 ($million)
- 5.6. Support Devices
- 5.6.1. Market size and forecast, 2021-2031 ($million)
- 5.6.2. Market size and forecast, by region, 2021-2031 ($million)
- Chapter 6. Embolotherapy Market by Application
- 6.1. Market overview
- 6.2. Oncology
- 6.2.1. Market size and forecast, 2021-2031 ($million)
- 6.2.2. Market size and forecast, by region, 2021-2031 ($million)
- 6.3. Peripheral Vascular Diseases
- 6.3.1. Market size and forecast, 2021-2031 ($million)
- 6.3.2. Market size and forecast, by region, 2021-2031 ($million)
- 6.4. Urology & Nephrology
- 6.4.1. Market size and forecast, 2021-2031 ($million)
- 6.4.2. Market size and forecast, by region, 2021-2031 ($million)
- 6.5. GIT Disorders
- 6.5.1. Market size and forecast, 2021-2031 ($million)
- 6.5.2. Market size and forecast, by region, 2021-2031 ($million)
- Chapter 7. Embolotherapy Market by Procedures
- 7.1. Market overview
- 7.2. Transcatheter Arterial Embolization
- 7.2.1. Market size and forecast, 2021-2031 ($million)
- 7.2.2. Market size and forecast, by region, 2021-2031 ($million)
- 7.3. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
- 7.3.1. Market size and forecast, 2021-2031 ($million)
- 7.3.2. Market size and forecast, by region, 2021-2031 ($million)
- 7.4. Transarterial Chemoembolization
- 7.4.1. Market size and forecast, 2021-2031 ($million)
- 7.4.2. Market size and forecast, by region, 2021-2031 ($million)
- Chapter 8. Embolotherapy Market by End Users
- 8.1. Market overview
- 8.2. Hospitals & Clinics
- 8.2.1. Market size and forecast, 2021-2031 ($million)
- 8.2.2. Market size and forecast, by region, 2021-2031 ($million)
- 8.3. Ambulatory Surgical Centers
- 8.3.1. Market size and forecast, 2021-2031 ($million)
- 8.3.2. Market size and forecast, by region, 2021-2031 ($million)
- 8.4. Others
- 8.4.1. Market size and forecast, 2021-2031 ($million)
- 8.4.2. Market size and forecast, by region, 2021-2031 ($million)
- Chapter 9. Global Embolotherapy Market, by Region
- 9.1. Overview
- 9.2. North America
- 9.2.1. Key market trends and opportunities
- 9.2.2. North America Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.2.3. North America Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.2.4. North America Embolotherapy market size and forecast by country, 2021-2031, ($million)
- 9.2.5. The u.s.
- 9.2.5.1. The u.s. Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.2.5.2. The u.s. Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.2.6. Canada
- 9.2.6.1. Canada Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.2.6.2. Canada Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.2.7. Mexico
- 9.2.7.1. Mexico Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.2.7.2. Mexico Embolotherapy market size and forecast by End User Product, 2021-2031, ($million)
- 9.3. Europe
- 9.3.1. Key market trends and opportunities
- 9.3.2. Europe Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.3.3. Europe Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.3.4. Europe Embolotherapy market size and forecast by country, 2021-2031, ($million)
- 9.3.5. Germany
- 9.3.5.1. Germany Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.3.5.2. Germany Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.3.6. France
- 9.3.6.1. France Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.3.6.2. France Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.3.7. U.k.
- 9.3.7.1. U.k. Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.3.7.2. U.k. Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.3.8. Spain
- 9.3.8.1. Spain Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.3.8.2. Spain Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.3.9. Italy
- 9.3.9.1. Italy Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.3.9.2. Italy Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.3.10. Russia
- 9.3.10.1. Russia Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.3.10.2. Russia Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.3.11. Rest of Europe
- 9.3.11.1. Rest of Europe Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.3.11.2. Rest of Europe Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.4. Asia-pacific
- 9.4.1. Key market trends and opportunities
- 9.4.2. Asia-pacific Embolotherapy market size and forecast by country, 2021-2031, ($million)
- 9.4.3. Asia-pacific Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.4.4. Asia-pacific Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.4.5. China
- 9.4.5.1. China Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.4.5.2. China Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.4.6. India
- 9.4.6.1. India Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.4.6.2. India Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.4.7. Japan
- 9.4.7.1. Japan Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.4.7.2. Japan Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.4.8. South Korea
- 9.4.8.1. South Korea Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.4.8.2. South Korea Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.4.9. Rest of APAC
- 9.4.9.1. Rest of APAC Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.4.9.2. Rest of APAC Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.5. Rest of the world
- 9.5.1. Key market trends and opportunities
- 9.5.2. Rest of the world Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.5.3. Rest of the world Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.5.4. Rest of the world Embolotherapy market size and forecast by country, 2021-2031, ($million)
- 9.5.5. Latin America
- 9.5.5.1. Latin America Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.5.5.2. Latin America Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.5.6. Middle east
- 9.5.6.1. Middle east Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.5.6.2. Middle east Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- 9.5.7. Africa
- 9.5.7.1. Africa Embolotherapy market size and forecast by Product, 2021-2031, ($million)
- 9.5.7.2. Africa Embolotherapy market size and forecast by End User, 2021-2031, ($million)
- Chapter 10. Competitive Landscape
- 10.1. Market overview
- 10.2. Market share analysis/key player positioning
- 10.3. Developmental strategy benchmarking
- 10.3.1. New End User development
- 10.3.2. Product launches
- 10.3.3. Business expansions
- 10.3.4. Partnerships, joint ventures, and collaborations
- 10.3.5. Mergers and acquisitions
- Chapter 11. Company Profiles
- 11.1. Boston Scientific Corporation (US)
- 11.1.1. Company snapshot
- 11.1.2. Financial performance
- 11.1.3. Product offerings
- 11.1.4. Key strategic initiatives
- 11.1.5. SWOT analysis
- 11.2. Merit Medical Systems (US)
- 11.2.1. Company snapshot
- 11.2.2. Financial performance
- 11.2.3. Product offerings
- 11.2.4. Key strategic initiatives
- 11.2.5. SWOT analysis
- 11.3. Terumo Corporation (Japan)
- 11.3.1. Company snapshot
- 11.3.2. Financial performance
- 11.3.3. Product offerings
- 11.3.4. Key strategic initiatives
- 11.3.5. SWOT analysis
- 11.4. Medtronic plc (Ireland)
- 11.4.1. Company snapshot
- 11.4.2. Financial performance
- 11.4.3. Product offerings
- 11.4.4. Key strategic initiatives
- 11.4.5. SWOT analysis
- 11.5. Johnson & Johnson (US)
- 11.5.1. Company snapshot
- 11.5.2. Financial performance
- 11.5.3. Product offerings
- 11.5.4. Key strategic initiatives
- 11.5.5. SWOT analysis
- 11.6. Stryker Corporation (US)
- 11.6.1. Company snapshot
- 11.6.2. Financial performance
- 11.6.3. Product offerings
- 11.6.4. Key strategic initiatives
- 11.6.5. SWOT analysis
- 11.7. BTG plc (UK)
- 11.7.1. Company snapshot
- 11.7.2. Financial performance
- 11.7.3. Product offerings
- 11.7.4. Key strategic initiatives
- 11.7.5. SWOT analysis
- 11.8. Penumbra, Inc. (US)
- 11.8.1. Company snapshot
- 11.8.2. Financial performance
- 11.8.3. Product offerings
- 11.8.4. Key strategic initiatives
- 11.8.5. SWOT analysis
- 11.9. Cook Medical (US)
- 11.9.1. Company snapshot
- 11.9.2. Financial performance
- 11.9.3. Product offerings
- 11.9.4. Key strategic initiatives
- 11.9.5. SWOT analysis
- 11.10. Abbott Laboratories (US)
- 11.10.1. Company snapshot
- 11.10.2. Financial performance
- 11.10.3. Product offerings
- 11.10.4. Key strategic initiatives
- 11.10.5. SWOT analysis
- *the list of company is subject to change during the final compilation of the report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
